NetworkNewsBreaks

MondayApr 20, 2026 3:50 pm

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial Coverage Highlighting Breakdown of GPS Reliability and Rise of AI-Driven Navigation in Modern Warfare

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising.  SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) is featured in recent AINewsWire editorial coverage highlighting the accelerating breakdown of GPS reliability in modern warfare, where satellite signals are increasingly jammed and spoofed, disrupting drone operations and mission effectiveness. Against this backdrop, the company’s Overwatch platform delivers a software-only solution for navigation and precision targeting in GPS-denied environments, enabling rapid deployment without hardware modifications and positioning SPARC AI to address a growing global defense requirement. The AINewsWire coverage also places SPARC AI alongside peers including Swarmer Inc. (NASDAQ: SWMR), Unusual Machines Inc. (NYSE American: UMAC), AgEagle Aerial…

Continue Reading

MondayApr 20, 2026 3:41 pm

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial Highlighting Biotech’s Shift Toward Science-Driven Asset Valuation

Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage highlighting a fundamental shift in biotechnology, where scientific progress is increasingly recognized as measurable financial value rather than purely as research expenditure. As clinical-stage assets advance toward commercialization, fair-value accounting frameworks under U.S. GAAP are enabling companies to reflect pipeline progress, probability of success and timing of market entry directly on the balance sheet. Within this evolving landscape, Oncotelic exemplifies the trend through its diversified oncology pipeline and strategic holdings, including its 45% stake in GMP Bio, recently measured at an enterprise value exceeding $1 billion, demonstrating how advancing science can materially strengthen financial positioning.  The BioMedWire editorial also situates Oncotelic alongside a group…

Continue Reading

MondayApr 20, 2026 3:34 pm

NetworkNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Begins Drill Mobilization At Murdock Mountain Project 

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.  Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) announced drill mobilization is underway for its 2026 exploration program at the Murdock Mountain Project, following completion of pad construction and pre-clearance work, with FTE Drilling deploying equipment and personnel to site. The upcoming program will target further evaluation of the Meade Peak Upper Phosphate Zone, building on prior drilling that returned an average grade of 10.95% P₂O₅ over 4.20 metres, as the company advances toward refining its geological model and assessing the potential for a future NI 43-101 compliant resource estimate. To…

Continue Reading

MondayApr 20, 2026 3:23 pm

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Signs Second Ukrainian Drone Manufacturer For Overwatch Platform 

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising.  SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced it has signed a second Ukrainian drone manufacturer to its Overwatch platform, expanding distribution of its GPS-denied navigation and precision targeting software within a high-demand electronic warfare environment. The agreement establishes an additional independent channel into Ukraine, strengthens the company’s installed base and data pipeline for machine learning model enhancement, and supports its strategy to embed Overwatch as standard infrastructure across drone and robotic platforms, with all deployments subject to applicable export control and defense trade compliance requirements. To view the full press release,…

Continue Reading

MondayApr 20, 2026 3:12 pm

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Supports Executive Order To Accelerate Psychedelic Drug Development 

NRx Pharmaceuticals (NASDAQ: NRXP) welcomed a newly signed Executive Order aimed at accelerating medical treatments for serious mental illness, including expanded access to psychedelic therapies and faster regulatory pathways. The order directs the FDA to issue priority vouchers for qualifying breakthrough therapies and encourages broader use of clinical trial data and real-world evidence, aligning with NRx’s strategy as it advances its NRX-100 drug candidate and seeks regulatory support to address severe depression, PTSD and suicidality. To view the full press release, visit https://nnw.fm/mbw06 About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc. (www.nrxpharma.com), is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for…

Continue Reading

MondayApr 20, 2026 3:01 pm

NetworkNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Adopts Disclosure Policy And Updates Investment Strategy 

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.  Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced it has adopted a Disclosure, Confidentiality and Insider Trading Policy to strengthen compliance with Canadian securities laws, prevent selective disclosure and ensure proper handling of material information, while also updating its Investment Policy to include a focus on space technology and infrastructure, artificial intelligence, robotics and other disruptive technologies, reflecting the company’s commitment to innovation across emerging sectors. To view the full press release, visit https://nnw.fm/7MvJx About Planet Ventures Inc. Planet Ventures Inc. is an investment issuer that actively invests…

Continue Reading

MondayApr 20, 2026 3:00 pm

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Appoints Quenton Petersen as CEO, Transitions David Shan to Executive Chairman

Massimo Group (NASDAQ: MAMO) announced the appointment of Quenton Petersen as Chief Executive Officer, effective April 14, 2026, with David Shan transitioning to Executive Chairman while remaining actively involved in the Company’s strategic direction. Petersen, a nine-year veteran of the company, emphasized continued growth across utility vehicles and electric mobility, alongside a disciplined evaluation of opportunities to integrate advanced technologies such as AI-enabled features and expand into applications including facility operations and smart mobility. To view the full press release, visit https://nnw.fm/crlr3 About Massimo Group (NASDAQ: MAMO) Massimo Group is a manufacturer and distributor of powersports products. Headquartered in Texas, the company offers a full lineup of UTVs, ATVs and mini bikes built…

Continue Reading

MondayApr 20, 2026 3:00 pm

NetworkNewsBreaks – Genius Group Limited (NYSE: GNS) Closes $8 Million Registered Direct Offering 

Genius Group (NYSE: GNS) announced the closing of its previously disclosed registered direct offering, raising gross proceeds of approximately $8.0 million through the sale of 21,621,621 ordinary shares (or pre-funded warrants in lieu thereof). The offering was conducted under the Company’s effective shelf registration statement, with D. Boral Capital LLC serving as exclusive placement agent, and proceeds are expected to support the Company’s continued growth as an AI-powered education platform. To view the full press release, visit https://nnw.fm/ldDwQ About Genius Group Limited Genius Group Limited is an education group delivering AI-powered education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100…

Continue Reading

MondayApr 20, 2026 3:00 pm

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach 

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader  Soligenix (NASDAQ: SNGX) is emphasizing the strategic importance of patient-centric drug development, as outlined by CEO Christopher J. Schaber in a Clinical Leader guest column, which explores how reformulating therapies can improve access, adherence, and real-world viability. Drawing on the company’s experience with SGX945, Schaber explains that early clinical trials revealed a disconnect between IV-based delivery and the daily realities of patients with chronic rare diseases, prompting a shift toward a more practical, home-based subcutaneous approach. According to Schaber, operational challenges such as travel burden, treatment scheduling, and patient retention should be…

Continue Reading

MondayApr 20, 2026 2:33 pm

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) to Drill Historic Heap Leach Pads At Santa Fe Project 

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.  ESGold (CSE: ESAU) (OTCQB: ESAUF) announced it will commence sonic core drilling of historic heap leach pads at its Santa Fe Gold Mine Project in Nevada’s Walker Lane, with permits expected shortly and mobilization of a Boart Longyear LS 450 rig to follow. The planned program includes 95 holes totaling 1,740 meters to evaluate potential gold and silver resources from pads associated with historic production of approximately 359,000 ounces of gold and 700,000 ounces of silver, with the company highlighting the potential for low-cost reprocessing to enhance project economics and support future production and cash flow growth.  To view the…

Continue Reading